Longitudinally Heterogeneous Tumor Dose Optimizes Proton Broadbeam, Interlaced Minibeam, and FLASH Therapy.
FLASH
distal edge tracking
minibeam therapy
particle therapy
radiation therapy
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
21 Oct 2022
21 Oct 2022
Historique:
received:
09
09
2022
revised:
09
10
2022
accepted:
17
10
2022
entrez:
27
10
2022
pubmed:
28
10
2022
medline:
28
10
2022
Statut:
epublish
Résumé
The prerequisite of any radiation therapy modality (X-ray, electron, proton, and heavy ion) is meant to meet at least a minimum prescribed dose at any location in the tumor for the best tumor control. In addition, there is also an upper dose limit within the tumor according to the International Commission on Radiation Units (ICRU) recommendations in order to spare healthy tissue as well as possible. However, healthy tissue may profit from the lower side effects when waving this upper dose limit and allowing a larger heterogeneous dose deposition in the tumor, but maintaining the prescribed minimum dose level, particularly in proton minibeam therapy. Methods: Three different longitudinally heterogeneous proton irradiation modes and a standard spread-out Bragg peak (SOBP) irradiation mode are simulated for their depth-dose curves under the constraint of maintaining a minimum prescribed dose anywhere in the tumor region. Symmetric dose distributions of two opposing directions are overlaid in a 25 cm-thick water phantom containing a 5 cm-thick tumor region. Interlaced planar minibeam dose distributions are compared to those of a broadbeam using the same longitudinal dose profiles. Results and Conclusion: All longitudinally heterogeneous proton irradiation modes show a dose reduction in the healthy tissue compared to the common SOBP mode in the case of broad proton beams. The proton minibeam cases show eventually a much larger mean cell survival and thus a further reduced equivalent uniform dose (EUD) in the healthy tissue than any broadbeam case. In fact, the irradiation mode using only one proton energy from each side shows better sparing capabilities in the healthy tissue than the common spread-out Bragg peak irradiation mode with the option of a better dose fall-off at the tumor edges and an easier technical realization, particularly in view of proton minibeam irradiation at ultra-high dose rates larger than ~10 Gy/s (so-called FLASH irradiation modes).
Identifiants
pubmed: 36291946
pii: cancers14205162
doi: 10.3390/cancers14205162
pmc: PMC9601234
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Radiother Oncol. 2016 Apr;119(1):5-11
pubmed: 26922487
Med Phys. 2017 Nov;44(11):6096-6104
pubmed: 28880369
Phys Med Biol. 2012 Jun 7;57(11):3371-405
pubmed: 22572603
Sci Rep. 2020 Jan 28;10(1):1384
pubmed: 31992757
Med Phys. 2003 May;30(5):979-85
pubmed: 12773007
Phys Med Biol. 2014 Dec 7;59(23):7089-106
pubmed: 25365362
PLoS One. 2019 Sep 4;14(9):e0221454
pubmed: 31483811
Radiat Environ Biophys. 2013 Mar;52(1):123-33
pubmed: 23271171
Front Oncol. 2015 Dec 01;5:269
pubmed: 26649281
Clin Cancer Res. 2019 Jan 1;25(1):35-42
pubmed: 29875213
Phys Med Biol. 2021 Dec 16;66(24):
pubmed: 34847532
J Radiat Res. 2013 May;54(3):494-514
pubmed: 23266948
Phys Med Biol. 2018 Dec 19;64(1):01TR01
pubmed: 30523903
Clin Oncol (R Coll Radiol). 2015 Feb;27(2):70-6
pubmed: 25455408
PLoS One. 2019 Nov 25;14(11):e0224873
pubmed: 31765436
Med Phys. 2010 Oct;37(10):5330-40
pubmed: 21089768
Sci Rep. 2021 Feb 11;11(1):3533
pubmed: 33574390
Med Phys. 1997 Jan;24(1):103-10
pubmed: 9029544
Radiother Oncol. 2019 Oct;139:11-17
pubmed: 31253466
Radiat Res. 2012 Jun;177(6):804-12
pubmed: 22607585
Cancers (Basel). 2021 Dec 09;13(24):
pubmed: 34944825
Int J Radiat Oncol Biol Phys. 2021 Jan 1;109(1):76-83
pubmed: 32805301
Int J Radiat Oncol Biol Phys. 2016 May 1;95(1):234-241
pubmed: 26692028
Sci Transl Med. 2014 Jul 16;6(245):245ra93
pubmed: 25031268
Med Phys. 2018 Nov;45(11):e1036-e1050
pubmed: 30421803
Proc Natl Acad Sci U S A. 2006 Jun 20;103(25):9709-14
pubmed: 16760251
Med Phys. 2015 Feb;42(2):567-74
pubmed: 25652477
Int J Radiat Biol. 1997 May;71(5):531-42
pubmed: 9191898
Cancers (Basel). 2021 Mar 01;13(5):
pubmed: 33804336
Med Phys. 2021 Jun;48(6):2733-2749
pubmed: 33759211
Radiother Oncol. 2017 Sep;124(3):365-369
pubmed: 28545957
Med Phys. 2012 Jun;39(6):3089-101
pubmed: 22755694
Sci Rep. 2020 Jul 9;10(1):11368
pubmed: 32647361
Phys Med Biol. 2017 May 21;62(10):3958-3982
pubmed: 28406796
Sci Rep. 2017 Oct 31;7(1):14403
pubmed: 29089533
Med Phys. 2019 Aug;46(8):3640-3648
pubmed: 31173369
Int J Med Sci. 2012;9(3):193-9
pubmed: 22408567